Synthesis and cytotoxic and analgesic activities of some 1, 5-diaryl-3-ethoxycarbonylpyrrole derivatives

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 21, Issue 1, 2006, Pages 113-118

  Demirayak, Seref ^a   Beis, Rana ^a   Karaburun, Ahmet C ^a   Kayagil, Ismail ^a   Incesu, Zerrin ^a   Ucucu, Umit ^a  

^a ANADOLU UNIVERSITY   (Turkey)

Author keywords

Analgesic activity; Cytotoxicity; Diarylpyrrole

Indexed keywords

1 ARYL 3 ETHOXYCARBONYLPENT 1,4 DIONE DERIVATIVE; 1,5 DIARYL 3 ETHOXYCARBONYL 2 METHYLPYRROLE DERIVATIVE; ACETYLSALICYLIC ACID; ANILINE DERIVATIVE; CYCLOOXYGENASE 2 INHIBITOR; DIMETHYL SULFOXIDE; MORPHINE SULFATE; SULFANILAMIDE; UNCLASSIFIED DRUG; ANALGESIC AGENT; PYRROLE DERIVATIVE;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TAIL FLICK TEST; ANIMAL; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; EMBRYO; FIBROBLAST; SYNTHESIS; TAIL;

ANALGESICS; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; EMBRYO; FEMALE; FIBROBLASTS; MALE; MICE; PYRROLES; RATS; TAIL;

EID: 33646106792     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360500472845     Document Type: Article

References (19)

1. Talley, JJ. (1999) Selective inhibitors of cyclooxygenase-2 (COX-2) Progr Med Chem, 36, pp. 201-234.
2. Dannhardt, G and Kiefer, W. (2001) Cyclooxygenase inhibitors - current status and future prospects Eur J Med Chem, 36, pp. 109-126.
3. Gauthier, JY and Lablanc, Y and Black, WC and Chan, C and Cromlish, WA and Gordon, R and Kennedey, BP and Lau, CK and Leger, S and Wang, Z and Ethier, D and Guay, J and Mancini, J and Riendeau, D and Tagari, P and Vickers, P and Wong, E and Xu, L and Prasit, P. (1996) Synthesis and biological evaluation of 2,3-diarylthiophenes as selective COX-2 inhibitors. Part II: Replacing the heterocycle Bioorg Med Chem Lett, 6, pp. 87-92.
4. Tsuji, K and Nakamura, K and Ogino, T and Konushi, N and Tojo, T and Ochi, T and Seki, N and Matsuo, M. (1998) Studies on anti-inflammatory agents. VI. Synthesis and pharmacological properties of 2,3-diarylthiophenes Chem Pharm Bull, 46, pp. 279-286.
5. Portevin, B and Tordjman, C and Pastoureau, P and Bonnet, J and De Nanteuil, G. (2000) 1,3-Diaryl-4,5,6,7-tetrahydro-2H-isoindole derivatives: A new series of potent and selective COX-2 inhibitors in which a sulfonyl group is not a structural requisite J Med Chem, 43, pp. 4582-4593.
6. Puig, C and Crespo, MI and Godessart, N and Feixas, J and Ibarzo, J and Jimenez, JM and Soca, L and Cardelus, I and Heredia, A and Miralpeix, M and Puig, J and Beleta, J and Huerta, JM and Lopez, M and Segarra, V and Ryder, H and Palacios, JM. (2000) Synthesis and biological evaluation of 3,4-diaryloxazolones: A new class of orally active cyclooxgenase-2 inhibitors J Med Chem, 43, pp. 214-223.
7. Habeeb, AG and Rao, PNP and Knaus, EE. (2001) Design and synthesis of 4,5-diphenyl-4-isoxazolines: Novel inhibitors of cyclooxygenase-2 with analgesic and antiinflammatory activity J Med Chem, 44, pp. 2921-2927.
8. Laufer, SA and Wagner, GK. (2002) From imidazole to pyrimidines: New inhibitors of cytokine release J Med Chem, 45, pp. 2733-2740.
9. Hashimoto, H and Imamura, K and Haruta, J and Wakitani, K. (2002) 4-(4-Cyclooalkyl/aryl-oxazol-5-yl)benzenesulfonamides as selective cyclooxygenase-2 inhibitors: Enhancement of the selectivity by introduction of a fluorine atom and identification of a potent, highly selective, and orally active COX-2 inhibitor JTE-522 J Med Chem, 45, pp. 1511-1517.
10. Palomer, A and Cabre, F and Pascual, J and Campos, J and Trujillo, MA and Entrena, A and Gallo, MA and Garcia, L and Mauleon, D and Espinosa, A. (2002) Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models J Med Chem, 45, pp. 1402-1411.
11. Balsamo, A and Coletta, I and Guglielmotti, A and Landolfi, C and Mancini, F and Martinelli, A and Milanese, C and Minutolo, F and Nencetti, S and Orlandini, E and Pinza, M and Rapposelli, S and Rossello, A. (2003) Synthesis of heteroaromatic analogues of (2-aryl-1-cyclopentenyl-1-alkylidene)-(arylmethyloxy)amine COX-2 inhibitors: Effects on the inhibitory activity of the replacement of the cyclopentene central core with pyrazole, thiophene or isoxazole ring Eur. J Med Chem, 38, pp. 157-168.
12. Almansa, C and Alfon, J and de Arriba, AF and Cavalcanti, FL and Escamilla, I and Gomez, LA and Miralles, A and Soliva, R and Bartroli, J and Carceller, E and Merlos, M and Garcia-Rafanell, J. (2003) Synthesis and structure - activity relationship of a new series of COX-2 selective inhibitors: 1,5-diarylimidazoles J Med Chem, 46, pp. 3463-3475.
13. Pal, M and Veeramaneni, VR and Nagabelli, M and Kalleda, SR and Misra, P and Casturi, SR and Yeleswarapu, KR. (2003) Conformationally restricted 3,4-diarylfuranones (2,3a,4,5-tetrahydronaphthofuranones) as selective cyclooxygenase-2 inhibitors Bioorg Med Chem Lett, 13, pp. 1639-1643.
14. Joo, YH and Kim, JK and Kang, S and Noh, M and Ha, J and Choi, JK and Lim, KM and Lee, CH and Chung, S. (2003) 2,3-Diarylbenzopyran derivatives as a novel class of selective cyclooxgenase-2 inhibitors Bioorg Med Chem Lett, 13, pp. 413-417.
15. Demirayak, S and Karaburun, AC and Kiraz, N. (1999) Synthesis and antibacterial activities of some 1-[2-(substituted pyrrole1-yl)ethyl]-2-methyl-5-nitroimidazole derivatives Eur J Med Chem, 34, pp. 275-278.
16. Green, LM and Reade, JL and Ware, CF. (1984) Rapid colormetric assay for cell viability: Application to the quantitation of cytotoxic and growth inhibitory lymphokines J Immunol Met, 70, pp. 257-268.
17. Kumi-Diaka, J. (2002) Chemo sensitivity of human prostate cancer cells PC3 and LNCaP to genistein isoflavone and beta-lapachone Biology of The Cell., 94, pp. 37-44.
18. D'Amour, FE and Smith, DL. (1941) A method for determining loss of pain sensation J Pharmacol Exp Ther, 72, pp. 74-79.
19. Schmauss, C and Yaksh, TL. (1984) In vivo studies on spinal receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat J Pharmacol Exp Ther, 228, pp. 1-12.